Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis

European Journal of Immunology

Volumn 30, Issue 10, 2000, Pages 2935-2943

  Alexander, James ^a   Christine Carter, K ^a   Al Fasi, Nuri ^a   Satoskar, Abhay ^b   Brombacher, Frank ^c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Chemotherapy; IL 4; Leishmania donovani

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MESSENGER RNA; STIBOGLUCONATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOMODULATION; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

ANIMAL; ANTIBODIES, PROTOZOAN; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NITRIC-OXIDE SYNTHASE; RNA, MESSENGER; SPLEEN; SUPPORT, NON-U.S. GOV'T; TH1 CELLS; TH2 CELLS;

EID: 0033788429     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q     Document Type: Article

References (57)

1. Immunology of leishmaniasis
2. Neutralisation of IL-12 demonstrates the existence of discrete organ specific phases in the control of Leishmania donovani
3. Behaviour of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model
4. Experimental visceral leishmaniasis: Production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma
5. Leishmaniasis
6. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation
7. Disruption of the interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection
8. Differential production of Th1 and Th2-derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine visceral leishmaniasis
9. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis
10. Dichotomy of the human T cell response to Leishmania antigens.II. Absence of Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients
11. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma
12. Leishmaniasis and AIDS co-infection: The spanish experience
13. Requirement for T cells and the effect of lymphokines in successful chemotherapy for an intracellular infection
14. Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis
15. Immunochemotherapy for intracellular Leishmania donovani infection, interferon gamma plus pentavalent antimony
16. Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis
17. In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets
18. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system
19. IL-4 induces a Th2 response in Leishmania major-infected mice
20. 2 production and anti-leishmanial capacity of human cultured monocytes mediated by IFN-gamma
21. IL-4 deficient mice resist infection with Leishmania major
22. Susceptibility to Leishmania major in interleukin-4-deficient mice
23. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains
24. IL-13 is a susceptibility factor for Leishmania major infection
25. Differences between IL-4 and IL-4α deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signalling
26. Different roles for interleukin-4 during the course of Toxoplasma gondii infection
27. Endogenous interleukin-4 is required for development of protective CD4+ T Helper Type 1 cell responses to Candida albicans
28. Cytokine control of Leishmania infection in the BALB/c mouse: Enhancement and inhibition of parasite growth by local administration of IL-2 and IL-4 is species and time dependent
29. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis
30. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis
31. Macrophage microbicidal mechanisms in vivo: Reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani
32. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10 deficient mice
33. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor α production
34. Regulation of T-cell-dependent and independent IL-12 production by the three Th2-type cytokines IL-10, IL-6 and IL-4
35. Effects of interleukin-4 on monocyte functions: Comparison to interleukin-13
36. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients
37. The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4-producing cells
38. Polarization of IL-4- and IFN-γ-producing CD4+ T cells following activation of naive CD4+ T cells
39. Roles of IL-4 and IFN-γ in stabilizing the T helper cell type 1 and 2 phenotype
40. Interleukin-4 enhances interferongamma synthesis but inhibits development of interferon-gamma-producing cells
41. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction
42. Leishmania promastigotes evade interleukin-12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection
43. In susceptible mice Leishmania major induces very rapid interleukin-4 production by CD4+ T cells which are NK1.1-
44. IL-4 receptor alpha deficient BALB-c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection
45. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes
46. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection
47. B7-2 blockade enhances T-cell responses to Leishmania donovani
48. Blockade of CTLA4 enhances host resistance to the intracellular pathogen, Leishmania donovani
49. Leishmania-specific T cells expressing interferon-gamma (IFN-γ) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis
50. Efficient targeting of the IL-4 gene in a BALB/c embryonic cell line
51. The therapeutic effect of sodium stibogluconate in the BALB/c mice infected with L. donovani is organ dependent
52. Regulation of Leishmania populations within the host. I The variable course of Leishmania donovani infections in mice
53. Visceral leishmaniasis in the BALB/c mouse: Sodium stibogluconate treatment during acute and chronic stages of infection
54. The limitations of carrier mediated sodium stibogluconate chemotherapy in the BALB/c mouse model of visceral leishmaniasis
55. Standardisation of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
56. Analysis of cytokine mRNA and DNA: Detection and quantification by competitive polymerase chain reaction
57. An invitation to an open exchange of reagents and information of use for the measurement of cytokine mRNA levels by PCR